Showing results (31-40 of 377) with videos related to

Sort By:
Pageof 38
Leukemia Research|March 22, 2017
Haptoglobin is frequently low in patients with myelofibrosis: Clinical relevancePaolo Strati, Lucia Masarova, Prithviraj Bose, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2012
The role of JAK pathway dysregulation in the pathogenesis and treatment of acute myeloid leukemiaHun Ju Lee, Naval Daver, Hagop M Kantarjian, et al.
Oncology (Williston Park, N.Y.)|April 16, 2008
New therapeutic options in gastrointestinal stromal tumorsEytan Stein, Olivia Aranha, Mark Agulnik
Clinical Lymphoma, Myeloma & Leukemia|November 23, 2021
Infectious Complications Among Patients With AML Treated With Immune Checkpoint InhibitorsAmy Spallone, Ahmad S Alotaibi, Ying Jiang, et al.
Blood Cancer Journal|June 10, 2022
Resistance to targeted therapies: delving into FLT3 and IDHSai Prasad Desikan, Naval Daver, Courtney DiNardo, et al.
Current Oncology Reports|August 1, 2025
Current Treatment Strategies for FLT3-Mutated Acute Myeloid Leukemia in Patients not Candidates for Intensive ChemotherapyAlex Bataller, Nicholas J Short, Naval Daver, et al.
Advances in Experimental Medicine and Biology|March 22, 2017
Harnessing the Immune System Against Leukemia: Monoclonal Antibodies and Checkpoint Strategies for AMLLucia Masarova, Hagop Kantarjian, Guillermo Garcia-Mannero, et al.
Advances in Experimental Medicine and Biology|December 13, 2018
Update on Immunotherapy in AML and MDS: Monoclonal Antibodies and Checkpoint Inhibitors Paving the Road for Clinical PracticeLucia Masarova, Hagop Kantarjian, Farhad Ravandi, et al.
Leukemia & Lymphoma|July 7, 2017
The emerging role of immune checkpoint based approaches in AML and MDSPrajwal Boddu, Hagop Kantarjian, Guillermo Garcia-Manero, et al.
Annals of Hematology|March 31, 2021
High-throughput proteomic profiling reveals mechanisms of action of AMG925, a dual FLT3-CDK4/6 kinase inhibitor targeting AML and AML stem/progenitor cellsZhihong Zeng, Charlie Ly, Naval Daver, et al.
Pageof 38